Financing an optometry practice acquisition

An optometry practice presents a lender with a genuinely mixed asset base, and understanding that split is the key to putting together a realistic financing package. The dispensary looks a lot like a specialty retailer a lender already knows how to underwrite; the clinical exam side looks like the goodwill-heavy healthcare practice a lender is naturally more cautious about.

The dispensary side looks like retail financing

Dispensary inventory — frames, lenses and contact-lens stock — along with the retail fixtures and point-of-sale equipment, is genuinely tangible collateral, and lenders are comfortable financing it in roughly the same way they would finance any specialty retail acquisition. The stronger and more diversified the dispensary’s supplier relationships, the more straightforward this part of the financing tends to be, since a lender can see a clear path to liquidating or replacing that inventory if it needed to. Come prepared with a current inventory count and turnover figures by product category, rather than a single dispensary revenue line, since that is the level of detail a lender actually needs to underwrite the retail portion of the loan.

Diagnostic equipment financing runs on its own track

OCT, visual field and retinal imaging equipment is typically financed separately from the broader acquisition loan, through equipment financing or leasing specific to that asset. If the equipment is aging toward the end of its useful life, factor the coming replacement cost into your financing plan now — a lender assessing the deal will, and an unplanned capital call in year one or two is a common way a new owner’s cash flow gets squeezed.

Why the exam-side goodwill is harder to finance

The value sitting in exam volume, recall discipline and payer mix is real, but it is harder for a lender to lend heavily against than a hard asset, particularly if the recall base has not been independently verified. A diversified payer mix across provincial coverage, private insurance and private pay reads as lower risk to a lender than heavy reliance on one payer category or on coverage rules that could shift. Come to a lender with the recall data already tested and the payer mix already broken down — it materially changes how much a lender is willing to lend against that side of the practice. A practice that can show several consecutive years of stable or growing exam volume, verified against actual bookings rather than a patient count, will generally find this part of the financing conversation considerably easier than one relying on an untested historical average.

How the purchase structure changes what can be financed

Whether the transaction is structured as an asset purchase or a share purchase affects which parts of an optometry practice a lender can cleanly finance. In an asset purchase, a lender can generally identify and lend against specific assets being acquired — dispensary inventory, equipment, fixtures — more directly than in a share purchase, where financing effectively covers the whole corporate entity, including the professional corporation structure and anything attached to it. Because ownership of the clinical entity is restricted to a licensed optometrist in several provinces, the share-purchase route is often the only one available when a non-optometrist buyer is using a management services organization structure, which means the financing conversation has to accommodate that reality rather than assume the simpler asset-purchase path is always open. Government-backed programs such as the Canada Small Business Financing Program can support the tangible-asset portion of an acquisition, subject to current program eligibility rules, and a BDC business-purchase loan is a common route lenders use for the broader transaction — confirm current terms directly with the program or your lender rather than assuming eligibility.

Where a vendor take-back and buy-in financing fit

Given how much of the price sits in goodwill a conventional lender won’t fully finance, a vendor take-back loan is a common way to bridge the gap, with the seller repaid over time out of the practice’s ongoing earnings — which also keeps the seller motivated to help the exam-side goodwill actually survive the transition. An associate doing an internal buy-in is often financed differently again, sometimes with practice-assisted or seller-financed terms, because the associate is a known quantity to both the seller and, often, the lender, which can make that path faster than financing an outside buyer from scratch.

What the lender will want to see before it commits

Expect a lender to want your ownership structure already confirmed — your own provincial registration if you are an optometrist, or a working management services organization structure if you are not — before it will commit to acquisition financing, since an unresolved ownership question is a real risk to the loan closing at all. Beyond that, associate coverage that reduces dependence on any single optometrist, and a diversified payer mix, are the two things most likely to move a lender from cautious to comfortable.